Novartis | Zobowiązania Handlowe



Trade Creditors Zmiana Data
AbbVie 2.94B 2.66B 2024-12
Amgen USD 2.41B 498M 2025-03
AstraZeneca 22.54B 79M 2025-03
Bausch Health Companies USD 620M 36M 2025-03
Biogen USD 391.5M 32.7M 2025-03
Bristol-Myers Squibb USD 4B 400M 2025-03
Canopy Growth CAD 28.92M 3.43M 2024-12
Corcept Therapeutics USD 27.95M 12.57M 2025-03
Drreddys Laboratories INR 36.02B 246M 2024-12
Eli Lilly USD 3.44B 213.4M 2025-03
Gilead Sciences USD 833M 70M 2024-12
GlaxoSmithKline 15.15B 186M 2025-03
Glaxosmithkline 3.46B 10.01B 2024-12
Indivior 183M 120M 2025-03
J&J USD 9.54B 766M 2025-03
Merck USD 3.78B 295M 2025-03
Novartis USD 4.57B 485M 2024-12
Novartis USD 4.57B 485M 2024-12
Pacira USD 23.17M 4.04M 2025-03
Perrigo USD 502.3M 7.1M 2025-03
Pfizer USD 5.24B 393M 2025-03
Prestige Brands USD 18.92M 581K 2025-03
Roche Holding 4.35B 828M 2024-12
Sanofi 21.62B 14.07B 2025-03
Sanofi 7.55B 118M 2024-12
Supernus Pharmaceuticals USD 4.59M 1.8M 2024-12
Zoetis USD 420M 13M 2025-03



Novartis Zobowiązania Handlowe - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.